AI Reshapes Labor Market BlueCollar Skilled Trades Gain as WhiteCollar Entry Jobs Slow EU Plans to Impose Significant Fine on Google Handelsblatt Reports FAA Orders SpaceX Investigation into Starship Booster Anomaly Kevin Warshs Potential Fed Leadership Could Reshape Wall Streets Plumbing Geopolitical Tensions Escalate as Iran Refuses to Bow Trump Rejects Peace Offer Potentially Impacting Global Energy Markets Zscaler Stock Drops as Weak Outlook and Sales Restructuring Concern Investors BRFH Q1 2026 Earnings EPS Surprise Beat Drives Stock Higher Amid Revenue Disclosures Uncertainty IPSC Q1 2026 Earnings EPS Beats Estimates Stock Declines Slightly as Pipeline Advances VEEE Q2 2025 Earnings Narrower Loss Propels Stock Higher Amid Strategic Transition SNYR Q1 2026 Earnings Significant EPS Miss Amid Lack of Revenue Disclosure MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Conditions SOBO Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds RiverNorth Managed Duration Municipal Income Fund RMM Advances 127 as Bond Markets Stabilize Reliance Global Group Inc EZRA Edges Lower Amid Cautious Trading HCA Healthcare Edges Higher as Support Levels Firm Up Sea Limited SE Declines 12 Tests Key Support Zone Seabridge Gold SA Holds Steady Near Resistance as Gold Market Consolidates Consumer Sentiment Slides to Fresh Record Low in May as Iran Conflict Fuels Inflation Concerns KLAR Q1 2026 Earnings Narrowed Loss Beats Estimates Driving Strong Stock Gains Definium Therapeutics DFTX Retreats Marginally as Key Support Holds at 2138 Addus HomeCare ADUS Q1 2026 Earnings Earnings Beat Despite Soft Stock Reaction Westwater Resources Inc WWR Q1 2026 Earnings Narrow Loss Beats Estimates as Stock Surges 25 MGY Q1 2026 Earnings EPS Beats Expectations as Operational Efficiency Drives Surprise AM Q1 2026 Earnings EPS Misses Estimates Stock Declines 149 Caleres CAL Q1 2026 Earnings EPS Beat Helps Narrow Loss Stock Gains 38 NLY Q1 2026 Earnings Modest EPS Beat as Mortgage REIT Faces Steady Rate Environment COCP Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline